Finnegan Recognized as a Leading Firm in the 2025 LMG Life Sciences Americas Rankings

FOR IMMEDIATE RELEASE
October 1, 2025

WASHINGTON, DC—Finnegan is proud to announce that the firm and a dozen of its attorneys have been recognized in the LMG Life Sciences Americas 2025 rankings, which recognizes the leading firms and practitioners for their exceptional legal counsel within the Life Sciences industry. Finnegan received Tier 1 rankings in all major IP categories, including General Patent Litigation; Hatch-Waxman Patent Litigation (Branded); Patent Prosecution; and Patent Strategy & Management. Released annually, the LMG Life Sciences rankings are determined through a comprehensive research process that includes analysis of case evidence, peer and client feedback, and evaluation of firm and attorney expertise within the life sciences sector.

Finnegan’ Life Sciences practice includes attorneys and IP professionals with advanced degrees in relevant scientific disciplines such as biology, chemistry, biochemistry, medicine, pharmacology, biomedical engineering, or electrical engineering. A significant number have substantial research and/or industry experience, and many joined Finnegan after holding positions in industry, at universities, or as examiners with the U.S. Patent and Trademark Office. The firm's mastery of intellectual property law, coupled with our backgrounds in the life and physical sciences and our experience in the industry, provide us with the necessary resources and technical expertise to address the most complex scientific issues. Our attorneys have drafted and prosecuted thousands of applications in the areas of biotechnology, pharmaceuticals, biologics, life science-related chemicals, and medical devices, and continue to be leaders in representing innovative pharmaceutical companies against patent challenges. Underscoring the firm’s excellence in Hatch-Waxman patent litigation (branded), Finnegan averages more than 100 ongoing ANDA litigations each year, encompassing bet-the-company products for smaller companies and multi-billion-dollar products for pharmaceutical giants.

In addition to the firm’s recognition, twelve Finnegan attorneys were individually ranked for their outstanding contributions to the Life Sciences industry. These attorneys include:

Michele C. Bosch - General Patent Litigation, Patent Strategy & Management
L. Scott Burwell - General Patent Litigation, Hatch-Waxman Patent Litigation
Bryan C. Diner - Patent Strategy & Management, Hatch-Waxman Patent Litigation
Mark J. Feldstein, Ph.D. - General Patent Litigation, Hatch-Waxman Patent Litigation
Jeffrey M. Jacobstein - Patent Prosecution, Patent Strategy & Management
J. Michael Jakes - General Patent Litigation, Patent Strategy & Management
John D. Livingstone - Hatch-Waxman Patent Litigation, General Patent Litigator of the Year (South)
Leslie A. McDonell - Patent Prosecution, Patent Strategy & Management
James B. Monroe - General Patent Litigation
William B. Raich, Ph.D. - General Patent Litigation
Jennifer Roscetti - General Patent Litigation
M. David Weingarten - Patent Prosecution, Patent Strategy & Management, Patent Strategy Attorney of the Year (South)

Recently, LMG Life Sciences hosted its 13th annual LMG Life Sciences Americas Awards , where Finnegan won three firm awards, including IP Boutique Firm of the Year, Patent Strategy Firm of the Year, and Hatch-Waxman Litigation Firm of the Year – Branded. Read more about the awards and the recipients here.

Contacts

Terra Liddell, Chief Marketing Officer
terra.liddell@finnegan.com

Angela Robinson, Director of Branding and Communications
angela.robinson@finnegan.com

About Finnegan
When your most valuable assets are ideas, innovation, and brand—you need the best to protect them. Finnegan, a premier intellectual property law firm, is trusted by global leaders to protect and advance what sets them apart. With 11 offices across the globe, we bring local insight and global reach to every IP challenge. We are located in Atlanta, Boston, London, Munich, Palo Alto, Reston, Seoul, Shanghai, Taipei, Tokyo and Washington, DC. From high-stakes litigation to cutting-edge patent strategy and innovative brand management, we deliver unmatched depth, agility, and results. If it is IP, it is Finnegan. Please visit us at www.finnegan.com or follow us on LinkedIn to see how we’re shaping the future of IP, one breakthrough at a time.